Variant report
Variant | nsv874884 |
---|---|
Chromosome Location | chr2:113772596-113777280 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35029104 | chr2:113772596-113772597 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs139591175 | chr2:113772708-113772709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78750054 | chr2:113772754-113772755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188618920 | chr2:113772805-113772806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567030723 | chr2:113772845-113772846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535932552 | chr2:113772850-113772851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555785224 | chr2:113772879-113772880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575968951 | chr2:113772911-113772912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545410128 | chr2:113772947-113772948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559215548 | chr2:113773054-113773055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576005172 | chr2:113773088-113773089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28394377 | chr2:113773104-113773105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541656839 | chr2:113773106-113773107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529588082 | chr2:113773124-113773125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561459343 | chr2:113773126-113773127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530266339 | chr2:113773138-113773139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549356330 | chr2:113773171-113773172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563568180 | chr2:113773172-113773173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559529573 | chr2:113773208-113773209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532555538 | chr2:113773257-113773258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34713475 | chr2:113773301-113773302 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs571521420 | chr2:113773329-113773330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35197197 | chr2:113773330-113773331 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs34626467 | chr2:113773373-113773374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34647471 | chr2:113773395-113773396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34488498 | chr2:113773485-113773486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567120469 | chr2:113773509-113773510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541693479 | chr2:113773544-113773545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1867831 | chr2:113773561-113773562 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs556206079 | chr2:113773601-113773602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569613626 | chr2:113773602-113773603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572855212 | chr2:113773608-113773609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558228855 | chr2:113773643-113773644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570283516 | chr2:113773645-113773646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572741595 | chr2:113773649-113773650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34762311 | chr2:113773656-113773657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535333954 | chr2:113773694-113773695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7562313 | chr2:113773709-113773710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116794040 | chr2:113773710-113773711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374507001 | chr2:113773717-113773718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537074361 | chr2:113773777-113773778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372275385 | chr2:113773781-113773782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs367829793 | chr2:113773862-113773863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563827121 | chr2:113773895-113773896 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35225653 | chr2:113774015-113774016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546187903 | chr2:113774065-113774066 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559478523 | chr2:113774087-113774088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149956175 | chr2:113774145-113774146 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35708381 | chr2:113774173-113774174 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs549595972 | chr2:113774185-113774186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113765600-113773000 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
2 | chr2:113765600-113797400 | Weak transcription | Gastric | stomach |
3 | chr2:113765800-113773000 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
4 | chr2:113768200-113773400 | Weak transcription | Fetal Thymus | thymus |
5 | chr2:113771400-113773800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr2:113772000-113773200 | Weak transcription | K562 | blood |
7 | chr2:113773000-113774000 | Enhancers | Primary T cells from cord blood | blood |
8 | chr2:113773000-113774000 | Enhancers | Primary T helper cells fromperipheralblood | blood |
9 | chr2:113773000-113774000 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
10 | chr2:113773000-113774600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
11 | chr2:113773200-113773600 | Enhancers | K562 | blood |
12 | chr2:113773200-113773800 | Enhancers | Primary T cells fromperipheralblood | blood |
13 | chr2:113773400-113773600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
14 | chr2:113773400-113773800 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
15 | chr2:113773400-113773800 | Enhancers | Fetal Thymus | thymus |
16 | chr2:113773400-113774000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
17 | chr2:113773400-113774600 | Enhancers | Stomach Mucosa | stomach |
18 | chr2:113774000-113774200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr2:113774000-113779400 | Weak transcription | Primary T cells from cord blood | blood |